BioCentury
ARTICLE | Company News

SRI International autoimmune news

July 16, 2012 7:00 AM UTC

The U.S. Department of Defense awarded SRI a one-year grant to develop an oral inhibitor of microRNA-326 (miR-326) to treat multiple sclerosis (MS). SRI said the product is in the early stage of deve...